VBI VACCINES INC.

Profile

Company Names

VBI VACCINES INC.
PAULSON CAPITAL CORP

Addresses

222 THIRD STREET, SUITE 2241, CAMBRIDGE, MA 02142

1331 NW LOVEJOY STREET, SUITE 720, PORTLAND, OR 97209

Phone Numbers

6178303031
5032436000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, INVESTMENT BANKING

Year Incorporated:

> 5 years ago

State Incorporated:

OREGON

Total Amount Raised:

$17,535,700.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-08-13 
$6,285,700.00 
$6,285,700.00 
$0.00 
Equity 
2
2014-07-25 
$11,000,000.00 
$11,000,000.00 
$0.00 
Equity 
1
2014-01-29 
$250,000.00 
$550,000.00 
$300,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
ANDERSON 
EXECUTIVE OFFICER
PLX PHARMA INC   |  AIKO BIOTECHNOLOGY INC   |  EREWARDS INC   |  HEADSPROUT INC   |  FISKER AUTOMOTIVE INC   |  MOLECULAR DETECTION, INC.   |  FISKER HOLDINGS, INC.   |  PLX PHARMA INC.   |  E-REWARDS INC   |  NANOSPECTRA BIOSCIENCES INC   |  ALTA VENTURES MEXICO FUND I, L.P.   |  VISION SCIENCES INC /DE/   |  OFFERCLICK, INC.   |  838 OAK STREET LLC   |  CAMBURY APARTMENTS LLC   |  SYNERGY BIOMEDICAL, LLC   |  EMBERCLEAR CORP.   |  TRANSCENDENT CAFE LLC   |  ONE PINE APARTMENTS, LLC   |  LAKESHORE APARTMENTS, LLC   |  VBI VACCINES INC.   |  STEELWEDGE SOFTWARE INC   |  PLACESTER, INC.   |  CANADIAN INTERNATIONAL OIL CORP.   |  FIREHOLE CRAFT BREWING CO   |  FB2 SERVICES, INC.   |  ACTUALMEDS CORP   |  FPB FINANCIAL CORP   |  VBI VACCINES INC/BC   |  IBC ADVANCED ALLOYS CORP.   |  ZSX MEDICAL, LLC   |  NEXTSHIFT ROBOTICS INC.   |  BASANITE, INC.   |  LUNGLIFE AI, INC.   |  BETTO, INC.   |  ANABIOS CORP   |  VERNAL BIOSCIENCES, INC.   |  AVIDIAN GOLD CORP.   |  GREENIDGE GENERATION HOLDINGS INC.   |  CARMELL CORP
JEFF 
 
BAXTER 
EXECUTIVE OFFICER, DIRECTOR
VARIATION BIOTECHNOLOGIES (US), INC.   |  VBI VACCINES INC.   |  VBI VACCINES INC/BC   |  CHROMADEX CORP.
ADAM 
T. 
BUCKLEY 
EXECUTIVE OFFICER
VBI VACCINES INC.
T. 
ADAM 
BUCKLEY 
EXECUTIVE OFFICER
VBI VACCINES INC.
SAM 
 
CHAWLA 
DIRECTOR
VBI VACCINES INC.   |  GREAT BASIN SCIENTIFIC, INC.   |  VBI VACCINES INC/BC   |  BRIDGE TO LIFE LTD
TRENT 
 
DAVIS 
EXECUTIVE OFFICER, DIRECTOR
PAULSON INVESTMENT I LLC   |  PAULSON CAPITAL CORP   |  VBI VACCINES INC.   |  EASTSIDE DISTILLING, INC.   |  MARICAP BLUE DOG 2019, L.P.   |  TBV MARICAP BLUE DOG 2019, LLC   |  PAULSON CAPITAL HOLDING COMPANY, LLC   |  INVO BIOSCIENCE, INC.
MICHEL 
 
DE WILDE 
DIRECTOR
VBI VACCINES INC.   |  VBI VACCINES INC/BC
MICHEL 
 
DEWILDE 
DIRECTOR
VBI VACCINES INC.
STEVE 
 
GILLIS 
DIRECTOR
XORI CORP   |  ONCOFACTOR CORP   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  LYCERA CORP   |  VBI VACCINES INC.   |  ONCORESPONSE INC   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP   |  MAGNOLIA NEUROSCIENCES CORP   |  VBI VACCINES INC/BC   |  ALLY THERAPEUTICS, INC.   |  SKYLARK BIO, INC.   |  BASKING BIOSCIENCES, INC.
MARC 
 
KIRCHMEIER 
EXECUTIVE OFFICER
VBI VACCINES INC.
EGIDIO 
 
NASCIMENTO 
EXECUTIVE OFFICER
VARIATION BIOTECHNOLOGIES (US), INC.   |  VBI VACCINES INC.   |  VBI VACCINES INC/BC
CHARLES 
L.F. 
PAULSON 
DIRECTOR
PAULSON CAPITAL CORP
CHESTER 
L.F. 
PAULSON 
PROMOTER
PAULSON INVESTMENT I LLC   |  PAULSON CAPITAL CORP
SHANNON 
P. 
PRATT, D.B.A. 
DIRECTOR
PAULSON CAPITAL CORP
PAUL 
F. 
SHOEN 
DIRECTOR
TRIANGLE T PARTNERS LLC   |  PAULSON CAPITAL CORP   |  EASTSIDE DISTILLING, INC.
MURRAY 
G. 
SMITH 
EXECUTIVE OFFICER
PAULSON CAPITAL CORP   |  GOLDEN MATRIX GROUP, INC.
MICHAEL 
 
STEINMETZ 
DIRECTOR
VIRDANTE PHARMACEUTICALS, INC.   |  TETRALOGIC PHARMACEUTICALS CORP   |  MACROGENICS INC   |  ALLOZYNE INC   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  LYCERA CORP   |  VBI VACCINES INC.
ALAN 
 
TIMMINS 
DIRECTOR
YAMHILL VALLEY VINEYARDS INC   |  VBI VACCINES INC.
ALAN 
P. 
TIMMINS 
DIRECTOR
PAULSON CAPITAL CORP   |  CYTODYN INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-08-26
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-08-13 
2014-08-08
D
Link
BIOTECHNOLOGY 
SECURITY BROKERS, DEALERS + FLOTATION COMPANIES [6211] 
DECLINE TO DISCLOSE 
Equity 
2014-07-25 
2014-08-08
D
Link
BIOTECHNOLOGY 
SECURITY BROKERS, DEALERS + FLOTATION COMPANIES [6211] 
DECLINE TO DISCLOSE 
Equity 
2014-07-25 
2014-02-12
D
Link
INVESTMENT BANKING 
SECURITY BROKERS, DEALERS + FLOTATION COMPANIES [6211] 
DECLINE TO DISCLOSE 
Equity 
2014-01-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
MIDDLEBURY SECURITIES, LLC
122602
MIDDLEBURY SECURITIES, LLC
122602